1. Home
  2. MRUS vs SLGN Comparison

MRUS vs SLGN Comparison

Compare MRUS & SLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • SLGN
  • Stock Information
  • Founded
  • MRUS 2003
  • SLGN 1987
  • Country
  • MRUS Netherlands
  • SLGN United States
  • Employees
  • MRUS N/A
  • SLGN N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • SLGN Containers/Packaging
  • Sector
  • MRUS Health Care
  • SLGN Industrials
  • Exchange
  • MRUS Nasdaq
  • SLGN Nasdaq
  • Market Cap
  • MRUS 5.1B
  • SLGN 4.6B
  • IPO Year
  • MRUS 2016
  • SLGN 1997
  • Fundamental
  • Price
  • MRUS $94.81
  • SLGN $38.66
  • Analyst Decision
  • MRUS Buy
  • SLGN Strong Buy
  • Analyst Count
  • MRUS 18
  • SLGN 9
  • Target Price
  • MRUS $93.72
  • SLGN $60.11
  • AVG Volume (30 Days)
  • MRUS 2.6M
  • SLGN 1.3M
  • Earning Date
  • MRUS 10-31-2025
  • SLGN 10-29-2025
  • Dividend Yield
  • MRUS N/A
  • SLGN 2.07%
  • EPS Growth
  • MRUS N/A
  • SLGN 6.68
  • EPS
  • MRUS N/A
  • SLGN 2.94
  • Revenue
  • MRUS $56,228,000.00
  • SLGN $6,425,794,000.00
  • Revenue This Year
  • MRUS $51.77
  • SLGN $11.86
  • Revenue Next Year
  • MRUS N/A
  • SLGN $2.89
  • P/E Ratio
  • MRUS N/A
  • SLGN $13.15
  • Revenue Growth
  • MRUS 59.77
  • SLGN 11.10
  • 52 Week Low
  • MRUS $33.19
  • SLGN $36.15
  • 52 Week High
  • MRUS $95.30
  • SLGN $58.14
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 79.21
  • SLGN 27.10
  • Support Level
  • MRUS $94.59
  • SLGN $44.13
  • Resistance Level
  • MRUS $95.06
  • SLGN $45.20
  • Average True Range (ATR)
  • MRUS 0.36
  • SLGN 1.14
  • MACD
  • MRUS -1.00
  • SLGN -0.12
  • Stochastic Oscillator
  • MRUS 47.87
  • SLGN 27.73

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About SLGN Silgan Holdings Inc.

Silgan Holdings manufactures about half of the metal food containers in North America. Its major customers include Campbell Soup, Nestle, and Del Monte. Silgan's other business segments include plastic dispensers and containers for personal and healthcare products and a closures business that manufactures metal and plastic lids and caps.

Share on Social Networks: